CYP2J2(∗)7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Jemal Hussien, Makonnen, Eyasu, Yimer, Getnet, Seifu, Daniel, Bekele, Abebe, Assefa, Mathewos, Aseffa, Abraham, Howe, Rawleigh, Fotoohi, Alan, Hassan, Moustapha, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527746/
https://www.ncbi.nlm.nih.gov/pubmed/31139078
http://dx.doi.org/10.3389/fphar.2019.00481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527746/
https://www.ncbi.nlm.nih.gov/pubmed/31139078
http://dx.doi.org/10.3389/fphar.2019.00481

Ejemplares similares